全文获取类型
收费全文 | 691篇 |
免费 | 36篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 27篇 |
妇产科学 | 10篇 |
基础医学 | 55篇 |
口腔科学 | 76篇 |
临床医学 | 84篇 |
内科学 | 157篇 |
皮肤病学 | 9篇 |
神经病学 | 44篇 |
特种医学 | 45篇 |
外科学 | 72篇 |
综合类 | 25篇 |
预防医学 | 29篇 |
眼科学 | 4篇 |
药学 | 32篇 |
肿瘤学 | 74篇 |
出版年
2022年 | 5篇 |
2018年 | 15篇 |
2017年 | 10篇 |
2016年 | 7篇 |
2015年 | 18篇 |
2014年 | 19篇 |
2013年 | 20篇 |
2012年 | 17篇 |
2011年 | 15篇 |
2010年 | 35篇 |
2009年 | 28篇 |
2008年 | 17篇 |
2007年 | 31篇 |
2006年 | 13篇 |
2005年 | 19篇 |
2004年 | 11篇 |
2003年 | 14篇 |
2002年 | 11篇 |
2001年 | 10篇 |
2000年 | 9篇 |
1999年 | 12篇 |
1998年 | 30篇 |
1997年 | 18篇 |
1996年 | 25篇 |
1995年 | 12篇 |
1994年 | 12篇 |
1993年 | 15篇 |
1992年 | 9篇 |
1991年 | 14篇 |
1990年 | 11篇 |
1989年 | 17篇 |
1988年 | 20篇 |
1987年 | 13篇 |
1986年 | 10篇 |
1985年 | 10篇 |
1983年 | 12篇 |
1982年 | 11篇 |
1980年 | 6篇 |
1979年 | 7篇 |
1978年 | 6篇 |
1975年 | 5篇 |
1972年 | 6篇 |
1959年 | 15篇 |
1958年 | 16篇 |
1957年 | 14篇 |
1956年 | 10篇 |
1955年 | 15篇 |
1954年 | 19篇 |
1952年 | 5篇 |
1948年 | 4篇 |
排序方式: 共有747条查询结果,搜索用时 0 毫秒
71.
72.
N. J. ST. G. SAUNDERS Lecturer C. BARCLAY Registrar 《BJOG : an international journal of obstetrics and gynaecology》1988,95(10):1060-1062
Summary. In a randomized controlled study of wound suction drainage after transverse suprapubic incision for lower-segment caesarean section no significant advantages could be demonstrated for routine drainage in terms of wound infection, haematoma formation, duration of hospital stay or analgesic requirements. 相似文献
73.
74.
ST O'Sullivan MD FRCSI GT McGreal FRCS CM Reardon FRCSI DJ Hehir MCH FRCSI WO Kirwan MCH FRCSI MP Brady MCH FRCSI 《International journal of clinical practice》1997,51(5):289-292
During a four-year period, 308 patients presented following ingestion of foreign bodies. Ingestion was accidental in 272 cases (88.3%) and deliberate in the remainder. Symptoms at presentation included dysphagia, odynophagia, nausea and vomiting, chest pain and pharyngeal discomfort. Sixty-eight patients were asymptomatic. A policy of expectant management and selective endoscopy was employed. Following initial assessment 202 patients (65.6%) were discharged without treatment, 30 (9.7%) of whom were later reviewed as outpatients and did not require admission. Forty-nine patients (16%) were admitted for treatment; 27 had oesophagoscopy, five bronchoscopy and two had foreign body extraction with direct laryngoscopy. In nine patients who were endoscoped, no foreign body was identified. Twenty-seven others were referred to the otorhinolaryngology service in another hospital. There were no deaths in the group and morbidity was 1.2%. We conclude that a policy of selective endoscopy is safe and effective in the management of patients following ingestion of foreign bodies. 相似文献
75.
Herpes simplex virus (HSV) has been implicated as a major etiologic factor in the development of ulcerative mucositis in bone marrow transplant (BMT) recipients. In this study, 60 patients who received BMTs were evaluated for at least 30 days post-transplant for ulcerative mucositis and the presence of culturable HSV. Fifty-nine patients received prophylactic acyclovir. Forty-six patients developed ulcerative lesions and 45 of these were culture negative for HSV. Neither the source of transplant (autologous versus allogenic) nor the HSV antibody status of the patient affected the frequency of mucositis. The conditioning regimen appeared to be the most significant factor contributing to the severity of ulcerative mucositis. While the majority of ulcers occurred on movable nonkeratinized mucosa in BMT recipients, the usual sites of reactivation of intraoral HSV are nonmovable, keratinized mucosa. We conclude that HSV is probably not a major etiologic agent of mucositis in BMT recipients and that acyclovir is an effective agent in preventing HSV reactivation. 相似文献
76.
77.
Paul A ST JOHN 《中国药理学报》2009,(6):656-662
Nicotinic acetylcholine receptors (nAChRs) play critical roles throughout the body. Precise regulation of the cellular loca- tion and availability of nAChRs on neurons and target cells is critical to their proper function. Dynamic, post-translational regulation of nAChRs, particularly control of their movements among the different compartments of cells, is an important aspect of that regulation. A combination of new information and new techniques has the study of nAChR trafficking poised for new breakthroughs. 相似文献
78.
M. CARCAO J. ST LOUIS† M-C. POON‡ E. GRUNEBAUM§ S. LACROIX¶ A. M. STAIN V. S. BLANCHETTE G. E. RIVARD¶ ON BEHALF OF THE INHIBITOR SUBCOMMITTEE OF THE ASSOCIATION OF HEMOPHILIA CLINIC DIRECTORS OF CANADA 《Haemophilia》2006,12(1):7-18
When a high titre inhibitor develops in a patient with haemophilia, attempts are made to eradicate it through immune tolerance induction therapy (ITI) involving the frequent and regular administration of factor, usually for months to years. ITI is successful in only two thirds of patients prompting investigators to explore alternate regimens to use in haemophiliacs failing conventional ITI. Rituximab is an anti-CD20 monoclonal antibody, which has shown promise in the treatment of B-cell-mediated disorders. We developed a protocol for the use of rituximab in haemophilia A (HA) patients failing conventional ITI or in those haemophiliacs where the likelihood of success of conventional ITI is poor. Patients receive 375 mg m(-2) of intravenous rituximab weekly for 4 weeks followed by monthly (up to 5 months) until inhibitor disappearance and establishment of normal FVIII pharmacokinetics (recovery and half-life). Patients are concurrently placed on recombinant FVIII (100 U kg(-1) day(-1)). We have placed five haemophiliacs (four children with severe HA, and one adult with mild HA) on this protocol. In three patients (two with severe HA and one with mild HA) inhibitors disappeared although in neither severe haemophiliac did FVIII pharmacokinetics completely normalize. The fourth patient had a significant drop in inhibitor titres although not a complete disappearance of the inhibitor. All four of these patients ceased bleeding following rituximab. The fifth patient had no response to rituximab. This non-responding patient was not placed on concurrent FVIII. Our five cases suggest that rituximab may hold promise in the eradication of inhibitors. Prospective randomized studies are required to determine the value of this agent in inhibitor management. 相似文献
79.
Warren K. Laskey Nathaniel Reichek Martin ST.John Sutton William J. Untereker John W. Hirshfeld 《The American journal of cardiology》1983,52(7):852-858
Alterations in left ventricular (LV) mechanics have significant effects on myocardial oxygen consumption (MV?O22) as a result of changing LV pressure and dimensions. However, the effects of load alteration on MV?O22 in the setting of LV hypertrophy and LV dysfunction have not been well characterized. Therefore, we examined changes in LV mechanics and MV?O22 in 32 patients with varying degrees of LV hypertrophy and LV dysfunction before and after pharmacologic alteration of load. With phenylephrine or nitroglycerin-induced load alteration, changes in peak systolic meridional stress, mean systolic stress and the area of a stress-dimension loop all correlated modestly with changes in MV?O22 (r = 0.66, 0.62, 0.63, respectively). However, changes in the time integral of LV ejection stress, or shortening load, were significantly correlated with changes in MV?O22 (r = 0.88, p < 0.001). In particular, load reduction results in a beneficial effect on MV?O22. In addition, for a given change in LV systolic pressure, changes in shortening load (38 + 3.7%) were significantly greater than changes in tension-time index (13 ± 1.4%), thus providing a sensitive marker of alteration of mechanical load.We conclude that physiologic alterations in mechanical load in normal persons as well as patients with LV hypertrophy are reflected in significant changes in the time integral of LV ejection stress. These changes in shortening load, mediated by changing LV pressure and dimension, are significantly related to changes in MV?O22. 相似文献
80.
Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma [see comments] 总被引:1,自引:0,他引:1
Kuzel TM; Hurria A; Samuelson E; Tallman MS; Roenigk HH Jr; Rademaker AW; Rosen ST 《Blood》1996,87(3):906-911
We investigated the efficacy of 2-chlorodeoxyadenosine (2-CdA) therapy in patients with mycosis fungoides (MF) and the Sezary syndrome (SS). Between February 1991 and November 1993, 21 patients with relapsed or refractory MF/SS were treated with 2-CdA. 2-CdA was administered by continuous intravenous infusion at a dose of 0.1 mg/kg/d for 7 days initially (13 patients), but was subsequently reduced to 5 days (nine patients) due to hematologic toxicity. All patients had failed to respond to at least one prior treatment for MF/SS (median number of total prior therapies, five; median number of systemic prior therapies, three) and had an Eastern Cooperative Oncology Group performance status of two or better. Cycles were administered at 28-day intervals. Assessable patients received at least 5 days of 2-CdA. Fourteen patients received more than one cycle of 2-CdA. An overall response rate of 28% was achieved. Three patients (14%) had a complete response with a median duration of 4.5 months (range, 2.5 to 16). Three (14%) had a partial response with a median duration of 2 months (range, 2 to 4). Fifteen patients (72%) had no response. The most significant toxicities encountered were bone marrow suppression (62% of patients) and infectious complications (62% of patients). Thirty-eight percent of patients experienced no toxicity from 2-CdA. 2-CdA has activity as a single agent in patients with previously treated relapsed MF/SS. Studies in less heavily pretreated individuals with 2-CdA alone or in combination will be undertaken. 相似文献